Evaluation of Long-Term Outcomes of Direct Acting Antiviral Agents in Chronic Kidney Disease Subjects: A Single Center Cohort Study.

Journal of clinical medicine(2023)

引用 1|浏览4
暂无评分
摘要
DAAs provide a safe and effective cure for CHC in both CKD patients and KTRs with a favorable safety profile in the long-term follow-up.
更多
查看译文
关键词
direct acting antiviral agents,chronic kidney disease subjects,chronic kidney disease,kidney disease,long-term
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要